** EMVision Medical Devices EMV.AX slips as much as 10.3% to A$2.08; marks biggest one-day percent drop since February 17
** Co receives firm commitments to raise A$12 mln ($8 mln) via placement at A$1.94/share
** Issue price represents 16.4% discount to last close
** Funds will be used to reach major milestones, including commercialisation of co's emu device and supporting FDA submission over FY26 and FY27
** Co launches share purchase plan for eligible shareholders, who will be offered a maximum of A$30,000 worth of SPP shares at A$1.94/share
** Around 203,500 shares traded in stock's busiest day since April 22
** EMV last down 7.3%, paring YTD gains to 13.5%
($1 = A$1.4986)
(Reporting by Keshav Singh Chundawat in Bengaluru)
((Keshav.SinghChundawat@thomsonreuters.com))